Learn More
Apexbio Technology LLC Icotinib 610798-31-7 5mg

Supplier: Apexbio Technology LLC B14965
Icotinib (CAS 610798-31-7) is a small molecule inhibitor targeting the epidermal growth factor receptor (EGFR) tyrosine kinase exhibiting an in vitro IC50 of 5 nM EGFR a transmembrane tyrosine kinase receptor plays a central role in cell proliferation motility and apoptosis and is overexpressed in various cancers including non-small cell lung cancer (NSCLC) breast ovarian and head and neck cancers Icotinib inhibits EGF-induced EGFR phosphorylation and downstream tyrosine phosphorylation of intracellular proteins in human carcinoma A431 cells in a dose-dependent manner In animal models icotinib suppresses tumor growth without significant toxicity It is of interest for preclinical and clinical research on EGFR-driven malignancies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.